Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Prolonged survival of scavenger receptor class A-deficient mice from pulmonary Mycobacterium tuberculosis infection.

Sever-Chroneos Z, Tvinnereim A, Hunter RL, Chroneos ZC.

Tuberculosis (Edinb). 2011 Dec;91 Suppl 1:S69-74. doi: 10.1016/j.tube.2011.10.014. Epub 2011 Nov 15.

2.

GM-CSF modulates pulmonary resistance to influenza A infection.

Sever-Chroneos Z, Murthy A, Davis J, Florence JM, Kurdowska A, Krupa A, Tichelaar JW, White MR, Hartshorn KL, Kobzik L, Whitsett JA, Chroneos ZC.

Antiviral Res. 2011 Nov;92(2):319-28. doi: 10.1016/j.antiviral.2011.08.022. Epub 2011 Sep 8.

3.

Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A.

Sever-Chroneos Z, Krupa A, Davis J, Hasan M, Yang CH, Szeliga J, Herrmann M, Hussain M, Geisbrecht BV, Kobzik L, Chroneos ZC.

J Biol Chem. 2011 Feb 11;286(6):4854-70. doi: 10.1074/jbc.M110.125567. Epub 2010 Dec 1.

4.

Pulmonary surfactant: an immunological perspective.

Chroneos ZC, Sever-Chroneos Z, Shepherd VL.

Cell Physiol Biochem. 2010;25(1):13-26. doi: 10.1159/000272047. Epub 2009 Dec 22. Review.

5.

Pulmonary surfactant and tuberculosis.

Chroneos ZC, Midde K, Sever-Chroneos Z, Jagannath C.

Tuberculosis (Edinb). 2009 Dec;89 Suppl 1:S10-4. doi: 10.1016/S1472-9792(09)70005-8.

PMID:
20006297
6.

An antibody against the surfactant protein A (SP-A)-binding domain of the SP-A receptor inhibits T cell-mediated immune responses to Mycobacterium tuberculosis.

Samten B, Townsend JC, Sever-Chroneos Z, Pasquinelli V, Barnes PF, Chroneos ZC.

J Leukoc Biol. 2008 Jul;84(1):115-23. doi: 10.1189/jlb.1207835. Epub 2008 May 1.

7.

Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis.

Szeliga J, Daniel DS, Yang CH, Sever-Chroneos Z, Jagannath C, Chroneos ZC.

Tuberculosis (Edinb). 2008 Jan;88(1):7-20. Epub 2007 Oct 24.

8.

Bacterial expression of recombinant MyoXVIIIA domains.

Szeliga J, Jordan J, Yang CH, Sever-Chroneos Z, Chroneos ZC.

Anal Biochem. 2005 Nov 1;346(1):179-81. Epub 2005 Aug 2. No abstract available.

9.

Identification of the surfactant protein A receptor 210 as the unconventional myosin 18A.

Yang CH, Szeliga J, Jordan J, Faske S, Sever-Chroneos Z, Dorsett B, Christian RE, Settlage RE, Shabanowitz J, Hunt DF, Whitsett JA, Chroneos ZC.

J Biol Chem. 2005 Oct 14;280(41):34447-57. Epub 2005 Aug 8.

10.

DNA damage invokes mismatch repair-dependent cyclin D1 attenuation and retinoblastoma signaling pathways to inhibit CDK2.

Lan Z, Sever-Chroneos Z, Strobeck MW, Park CH, Baskaran R, Edelmann W, Leone G, Knudsen ES.

J Biol Chem. 2002 Mar 8;277(10):8372-81. Epub 2001 Nov 28.

11.

Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase.

Sever-Chroneos Z, Angus SP, Fribourg AF, Wan H, Todorov I, Knudsen KE, Knudsen ES.

Mol Cell Biol. 2001 Jun;21(12):4032-45.

12.

RB-dependent S-phase response to DNA damage.

Knudsen KE, Booth D, Naderi S, Sever-Chroneos Z, Fribourg AF, Hunton IC, Feramisco JR, Wang JY, Knudsen ES.

Mol Cell Biol. 2000 Oct;20(20):7751-63.

13.

Regulation of mouse SP-B gene promoter by AP-1 family members.

Sever-Chroneos Z, Bachurski CJ, Yan C, Whitsett JA.

Am J Physiol. 1999 Jul;277(1):L79-88. doi: 10.1152/ajplung.1999.277.1.L79.

PMID:
10409233

Supplemental Content

Loading ...
Support Center